Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Dementia is relatively common in Parkinson's Disease (PD). When dementia occurs in the setting of PD, it is referred to as Parkinson's disease dementia (PDD), which is distinguished from the clinical syndrome in which dementia precedes extrapyramidal features, dementia with Lewy bodies (DLB). In this report, the neuropathology of PDD and DLB is reviewed and preliminary findings are reported on striatal pathology in 28 brains, including 7 PD, 7 PDD and 14 DLB. Sections of putamen immunostained for a-synuclein and investigated with image analysis show that striatal pathology is common and that both cortical and striatal a-synuclein pathology is greater in PDD and DLB than PD. Most cases of PDD and DLB have Alzheimer-type pathology, particularly amyloid plaques, which may act in an additive or synergistic manner with a-synuclein pathology. There are few pathologic differences between PDD and DLB, despite differences in their clinical course.
Tsuboi
Yoshio
Y
Fifth Department of Internal Medicine, Fukuoka University, Fukuoka, Japan.
Uchikado
Hirotake
H
Dickson
Dennis W
DW
D000368:Aged; D000369:Aged, 80 and over; D003342:Corpus Striatum / Q000737:chemistry / Q000473:pathology*; D003704:Dementia / Q000378:metabolism / Q000473:pathology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D020961:Lewy Body Disease / Q000378:metabolism / Q000473:pathology*; D008297:Male; D010300:Parkinson Disease / Q000378:metabolism / Q000473:pathology*; D051844:alpha-Synuclein / Q000378:metabolism
D051844:alpha-Synuclein